Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Regulation of microRNAs in Alzheimer's Disease
Xianjuan Kou, Dandan Chen, Ning Chen
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses
Mohammad Nasb, Weichu Tao, Ning Chen
Aging and Disease (2023)
Open Access | Times Cited: 58
Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Neurochemistry International (2024) Vol. 177, pp. 105761-105761
Closed Access | Times Cited: 15
MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
Yao-Bo Li, Qiang Fu, Mei Guo, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 15
microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
Yuhai Zhao, Vivian Jaber, Peter N. Alexandrov, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 79
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases
T. P. Nhung Nguyen, Mandeep Kumar, Ernesto Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4718-4718
Open Access | Times Cited: 50
Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer’s Disease
Yuqing Liu, Xin Cheng, Hongli Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
The Role of Brain-Derived Neurotrophic Factor (BDNF) in Diagnosis and Treatment of Epilepsy, Depression, Schizophrenia, Anorexia Nervosa and Alzheimer’s Disease as Highly Drug-Resistant Diseases: A Narrative Review
Aleksandra Gliwińska, Justyna Czubilińska-Łada, Gniewko Więckiewicz, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 163-163
Open Access | Times Cited: 33
The beneficial role of autophagy in multiple sclerosis: Yes or No?
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Autophagy (2023) Vol. 20, Iss. 2, pp. 259-274
Open Access | Times Cited: 29
Microglial Activation in Metal Neurotoxicity: Impact in Neurodegenerative Diseases
María I. Martínez-Hernández, Leonor C. Acosta‐Saavedra, Luisa C. Hernández‐Kelly, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 27
The Brain–Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review
Eugenio Caradonna, Raffaello Nemni, Angelo Bifone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4130-4130
Open Access | Times Cited: 12
miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease
Sang‐Won Han, Jung‐Min Pyun, Paula J. Bice, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
MicroRNAs and synapse turnover in Alzheimer’s disease
Sarthak Dalal, Jaime Ramirez-Gomez, Bhupender Sharma, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102377-102377
Closed Access | Times Cited: 8
Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers
Meng Zhang, Ping He, Zhigang Bian
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 50
Exercise-Induced Benefits for Alzheimer’s Disease by Stimulating Mitophagy and Improving Mitochondrial Function
Jiling Liang, Cenyi Wang, Hu Zhang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 42
MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities
Nermeen Z. Abuelezz, Fayza Eid Nasr, Mohammad A. Abdulkader, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 42
Roles of the miR-155 in Neuroinflammation and Neurological Disorders: A Potent Biological and Therapeutic Target
Seyed Hamidreza Rastegar-Moghaddam, Alireza Ebrahimzadeh‐Bideskan, Sara Shahba, et al.
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 2, pp. 455-467
Closed Access | Times Cited: 35
Plasma microRNA vary in association with the progression of Alzheimer's disease
Diane Guévremont, Helen Tsui, Robert G. Knight, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 29
The role of microRNAs in neurobiology and pathophysiology of the hippocampus
Seyed Khalil Rashidi, Ata Kalirad, Shahram Rafie, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 21
Targeting autophagy in Alzheimer’s disease: Animal models and mechanisms
Xiaowen Zhang, Xiangxing Zhu, Dongsheng Tang, et al.
动物学研究 (2023) Vol. 44, Iss. 6, pp. 1132-1145
Open Access | Times Cited: 18
MicroRNAs: a symphony orchestrating evolution and disease dynamics
Shan Quah, Gowtham Subramanian, Jonathan S.L. Tan, et al.
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 6
Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease
Ming Zhang, Wei Han, Yuhao Xu, et al.
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 269-275
Open Access | Times Cited: 40
Unique molecular characteristics and microglial origin of Kv1.3 channel–positive brain myeloid cells in Alzheimer’s disease
Supriya Ramesha, Sruti Rayaprolu, Christine A Bowen, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 11
Open Access | Times Cited: 35
COVID−19, Anti-NMDA Receptor Encephalitis and MicroRNA
Hsiuying Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
MicroRNA-22: a Novel and Potent Biological Therapeutics in Neurological Disorders
Seyed Hamidreza Rastegar-Moghaddam, Alireza Ebrahimzadeh‐Bideskan, Sara Shahba, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 5, pp. 2694-2701
Closed Access | Times Cited: 24
Neuroprotection and Mechanism of Gas-miR36-5p from Gastrodia elata in an Alzheimer’s Disease Model by Regulating Glycogen Synthase Kinase-3β
Zhongteng Lu, Jianyuan Fu, Guang Wu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17295-17295
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top